Enzo Biochem (ENZ) Competitors $0.32 -0.06 (-15.36%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$0.32 +0.00 (+0.62%) As of 04/17/2025 05:53 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ENZ vs. OPGN, BNR, CCM, MRAI, BRTX, KDLY, MGRX, OTRK, SSY, and ATPCShould you be buying Enzo Biochem stock or one of its competitors? The main competitors of Enzo Biochem include OpGen (OPGN), Burning Rock Biotech (BNR), Concord Medical Services (CCM), Marpai (MRAI), BioRestorative Therapies (BRTX), Kindly MD (KDLY), Mangoceuticals (MGRX), Ontrak (OTRK), SunLink Health Systems (SSY), and Agape ATP (ATPC). These companies are all part of the "healthcare" industry. Enzo Biochem vs. OpGen Burning Rock Biotech Concord Medical Services Marpai BioRestorative Therapies Kindly MD Mangoceuticals Ontrak SunLink Health Systems Agape ATP Enzo Biochem (NYSE:ENZ) and OpGen (NASDAQ:OPGN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their media sentiment, valuation, analyst recommendations, profitability, earnings, dividends, risk, institutional ownership and community ranking. Which has stronger valuation & earnings, ENZ or OPGN? Enzo Biochem has higher revenue and earnings than OpGen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEnzo Biochem$29.09M0.58-$26.08MN/AN/AOpGen$2.67M13.04-$32.67MN/AN/A Is ENZ or OPGN more profitable? Enzo Biochem has a net margin of -75.34% compared to OpGen's net margin of -1,140.36%. OpGen's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets Enzo Biochem-75.34% -7.96% -5.49% OpGen -1,140.36%N/A -287.58% Does the MarketBeat Community prefer ENZ or OPGN? OpGen received 89 more outperform votes than Enzo Biochem when rated by MarketBeat users. However, 52.74% of users gave Enzo Biochem an outperform vote while only 52.17% of users gave OpGen an outperform vote. CompanyUnderperformOutperformEnzo BiochemOutperform Votes21252.74% Underperform Votes19047.26% OpGenOutperform Votes30152.17% Underperform Votes27647.83% Do institutionals & insiders believe in ENZ or OPGN? 36.9% of Enzo Biochem shares are owned by institutional investors. Comparatively, 2.7% of OpGen shares are owned by institutional investors. 11.4% of Enzo Biochem shares are owned by company insiders. Comparatively, 43.8% of OpGen shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the media prefer ENZ or OPGN? In the previous week, Enzo Biochem had 1 more articles in the media than OpGen. MarketBeat recorded 1 mentions for Enzo Biochem and 0 mentions for OpGen. Enzo Biochem's average media sentiment score of 0.00 equaled OpGen'saverage media sentiment score. Company Overall Sentiment Enzo Biochem Neutral OpGen Neutral Which has more volatility & risk, ENZ or OPGN? Enzo Biochem has a beta of 1.19, suggesting that its stock price is 19% more volatile than the S&P 500. Comparatively, OpGen has a beta of -1.61, suggesting that its stock price is 261% less volatile than the S&P 500. SummaryEnzo Biochem beats OpGen on 8 of the 12 factors compared between the two stocks. Get Enzo Biochem News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ENZ vs. The Competition Export to ExcelMetricEnzo BiochemMedical laboratories IndustryMedical SectorNYSE ExchangeMarket Cap$16.93M$2.78B$5.30B$18.43BDividend Yield119.72%31.37%5.12%4.20%P/E RatioN/A14.4621.8031.09Price / Sales0.58192.58379.9626.56Price / CashN/A57.5638.2617.54Price / Book0.304.486.444.30Net Income-$26.08M-$22.21M$3.21B$1.02B7 Day Performance3.53%1.82%2.88%1.42%1 Month Performance-35.91%-6.62%-8.63%-7.33%1 Year Performance-71.16%6.40%11.46%2.26% Enzo Biochem Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ENZEnzo Biochem0.566 of 5 stars$0.32-15.4%N/A-71.9%$16.93M$29.09M0.00520Analyst ForecastGap DownHigh Trading VolumeOPGNOpGenN/A$4.04+3.6%N/A-30.5%$33.76M$2.67M0.00100Analyst ForecastGap DownBNRBurning Rock Biotech0.5029 of 5 stars$2.91-3.3%N/A-63.3%$29.81M$515.82M-0.971,390CCMConcord Medical Services0.3995 of 5 stars$4.22+5.0%N/A-33.7%$18.32M$471.70M0.00970Analyst ForecastNews CoverageGap DownHigh Trading VolumeMRAIMarpaiN/A$1.00+19.0%N/A-57.7%$14.90M$34.87M-0.38150Gap UpBRTXBioRestorative Therapies3.5876 of 5 stars$1.78-0.6%$18.00+911.2%+25.9%$13.36M$401,000.00-1.167Short Interest ↓KDLYKindly MD0.1613 of 5 stars$1.66-3.5%N/AN/A$10.01M$2.72M-2.52N/ANews CoverageGap UpMGRXMangoceuticals0.5209 of 5 stars$1.82+16.3%N/A-95.9%$9.41M$615,873.00-0.313Short Interest ↑OTRKOntrak2.8277 of 5 stars$1.66+5.8%$45.00+2,610.8%-74.3%$7.00M$11.24M-0.16250Earnings ReportShort Interest ↓Gap UpSSYSunLink Health SystemsN/A$0.85-4.7%N/A+34.1%$5.97M$31.23M6.061,376Gap UpATPCAgape ATP0.9623 of 5 stars$1.42+7.6%N/A-59.4%$5.67M$1.32M-1.9540Gap Up Related Companies and Tools Related Companies OpGen Competitors Burning Rock Biotech Competitors Concord Medical Services Competitors Marpai Competitors BioRestorative Therapies Competitors Kindly MD Competitors Mangoceuticals Competitors Ontrak Competitors SunLink Health Systems Competitors Agape ATP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ENZ) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored100-year-old investment secret predicts what?!A 100-year-old indicator has quietly predicted nearly every major market meltdown — including the Dot-Com Bust...Weiss Ratings | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | Sponsored2025 could be "worse than the dot-com bust", says man who predicted 2008 banking crisisWhat's coming next to the U.S. market could be worse than anything we've ever seen before – worse than the dot...Stansberry Research | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzo Biochem, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzo Biochem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ENZ Stock Free ENZ Stock Alerts